Apoglyx Competitors and Similar CompaniesClear all
Carmot Therapeutics's competitors and similar companies include BIOTON and Enthera Pharmaceuticals.
 Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. | ||
Founding Date | Founding Date 2008 | Founding Date 1989 | Founding Date 2016 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations Berkeley, US HQ | Locations Macierzysz, PL HQ | Locations Milan, IT HQ Milan, IT Milan, IT |
Employees | Employees 109% decrease | Employees 361 | Employees 225% increase |
Financial | |||
Net income | Net income ($38.8m) (FY, 2022) | Net income zł3.4m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 74.8m | Total funding raised N/A | Total funding raised $ 32.8m |
For sources of this data, please see the company profile
View Company Profiles
BIOTON
HQ
Macierzysz, PL
Employees
361
Bioton is a biotech company whose major therapeutic area is diabetes.
View companyEnthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View company